http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2604073-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3675d00f905863ab0ddd24d2bb60daf5
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-722
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
filingDate 1994-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b25560a0dba5e380288b7ebeb52a92d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0edb82a35697b7821510ea110e56312e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a42c90cd43f0a2a602be23d5ba4d7fe8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_faf28c183f32d5374c14748f740ec4fe
publicationDate 1995-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2604073-A1
titleOfInvention Poly-.beta.-1.fwdarw.4-n-acetylglucosamine
abstract A method of producing and purifying poly-.beta.-1.fwdarw.4-N-acetylflucosamine(p-GlcNAc)polysaccharide species and their derivatives is described. The polysaccharides produced by this method are free of proteins, and substantially free of single amino acids, and other organic and inorganic contaminants. These p-GlcNAc polysaccharides may be used commercially by the biomedical, pharmaceutical, and cosmetic industries in slow drug delivery systems, cell encapsulation systems, and treatments for the prevention of post-surgical adhesions. The figure shows the chemical structure of 100 % p-GlcNAc, wherein "n" is an integer from about 4,000 to about 150,000.
priorityDate 1993-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467890502

Total number of triples: 16.